However, targeting GM-CSF may not be straightforward in IBD as there are clear host protective functions of GM-CSF in the intestine (Sainathan et al., 2008; Bernasconi et al., 2010; Hirata et al., 2010). Here, CSF2 is linked to inflammatory bowel disease.